JP2005526757A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526757A5
JP2005526757A5 JP2003574172A JP2003574172A JP2005526757A5 JP 2005526757 A5 JP2005526757 A5 JP 2005526757A5 JP 2003574172 A JP2003574172 A JP 2003574172A JP 2003574172 A JP2003574172 A JP 2003574172A JP 2005526757 A5 JP2005526757 A5 JP 2005526757A5
Authority
JP
Japan
Prior art keywords
treatment system
coating
layer
tablet
coating film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003574172A
Other languages
English (en)
Japanese (ja)
Other versions
JP4664595B2 (ja
JP2005526757A (ja
Filing date
Publication date
Priority claimed from IT2002MI000514A external-priority patent/ITMI20020514A1/it
Application filed filed Critical
Publication of JP2005526757A publication Critical patent/JP2005526757A/ja
Publication of JP2005526757A5 publication Critical patent/JP2005526757A5/ja
Application granted granted Critical
Publication of JP4664595B2 publication Critical patent/JP4664595B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003574172A 2002-03-12 2003-03-12 活性成分の放出を制御する治療システム Expired - Fee Related JP4664595B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000514A ITMI20020514A1 (it) 2002-03-12 2002-03-12 Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
PCT/EP2003/002536 WO2003075897A1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients

Publications (3)

Publication Number Publication Date
JP2005526757A JP2005526757A (ja) 2005-09-08
JP2005526757A5 true JP2005526757A5 (https=) 2006-04-20
JP4664595B2 JP4664595B2 (ja) 2011-04-06

Family

ID=11449490

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003574172A Expired - Fee Related JP4664595B2 (ja) 2002-03-12 2003-03-12 活性成分の放出を制御する治療システム

Country Status (12)

Country Link
US (1) US20050095295A1 (https=)
EP (1) EP1482915B1 (https=)
JP (1) JP4664595B2 (https=)
CN (1) CN100528146C (https=)
AT (1) ATE454887T1 (https=)
AU (1) AU2003239789A1 (https=)
CA (1) CA2478406C (https=)
DE (1) DE60330949D1 (https=)
DK (1) DK1482915T3 (https=)
ES (1) ES2339438T3 (https=)
IT (1) ITMI20020514A1 (https=)
WO (1) WO2003075897A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
EP1429744A1 (en) 2001-09-21 2004-06-23 Egalet A/S Morphine polymer release system
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
WO2004084868A1 (en) 2003-03-26 2004-10-07 Egalet A/S Morphine controlled release system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US8163306B2 (en) * 2003-09-19 2012-04-24 Sun Pharma Advanced Research Company Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US20060280788A1 (en) * 2005-05-09 2006-12-14 Casey Stephen M Delivery and formulations of mast cell stabilizers
CA2611081C (en) * 2005-06-03 2016-05-31 Egalet A/S A drug delivery system for delivering active substances dispersed in a dispersion medium
EP1948138A4 (en) * 2005-11-18 2012-07-11 Accu Break Technologies Inc SEGMENTED PHARMACEUTICAL DOSAGE FORMS
CA2657437A1 (en) * 2006-06-19 2007-12-27 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
EP2155167A2 (en) 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
CN102026628A (zh) * 2008-02-15 2011-04-20 太阳医药高级研发有限公司 具有降低崩裂效果的口服控释片剂
AU2009308885A1 (en) * 2008-10-31 2010-05-06 Mcneil-Ppc, Inc. Osmotic tablet with a compressed outer coating
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
WO2010088911A1 (en) 2009-02-06 2010-08-12 Egalet A/S Pharmaceutical compositions resistant to abuse
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations
AU2012277375A1 (en) * 2011-06-29 2014-01-30 Sun Pharmaceutical Industries Limited Multilayered dosage form
BR112015000150A2 (pt) 2012-07-06 2017-06-27 Egalet Ltd composições farmacêuticas dissuasoras de abuso de liberação controlada
CN104490838B (zh) * 2014-11-20 2017-03-01 河北医科大学 一种骨架型缓控释片剂及其制备方法和应用
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
WO2017136617A1 (en) 2016-02-04 2017-08-10 Cinrx Pharma, Llc Deuterated domperidone compositions and methods for therapy of disorders
AU2017261372B2 (en) * 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
EA201992116A1 (ru) 2017-03-08 2020-01-29 СИНРКС ФАРМА, ЭлЭлСи Фармацевтические составы флороглюцинола и триметилфлороглюцинола
US12478612B2 (en) 2017-06-30 2025-11-25 Cindome Pharma, Inc. Deuterated domperidone compositions, methods, and preparation
EP3970701B1 (en) * 2018-06-27 2025-05-07 Amneal Complex Products Research LLC Self-regulating osmotic gastroretentive drug delivery systems
WO2020027927A1 (en) * 2018-07-30 2020-02-06 Insta Therapeutics, Inc. Sublingual diltiazem and methods of use
CN113274363B (zh) * 2021-04-29 2023-02-10 珠海润都制药股份有限公司 一种吲达帕胺制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4503030A (en) * 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5376771A (en) * 1992-07-07 1994-12-27 Merck & Co., Inc. High speed process for preparing orifices in pharmaceutical dosage forms
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
CN2213539Y (zh) * 1994-04-29 1995-11-29 天津市激光技术研究所 包衣上带有小孔的缓释药片
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US5783793A (en) * 1996-02-29 1998-07-21 Merck & Co., Inc. Process for producing a plurality of holes in dosage forms using a laser beam deflected by an acousto-optic deflector
CA2261787C (en) * 1997-05-30 2006-11-14 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
US6004584A (en) * 1998-03-02 1999-12-21 The Procter & Gamble Company Highly absorbent body powders
CA2378829A1 (en) * 1999-07-20 2001-01-25 Merck & Co., Inc. Sustained release drug dispersion delivery device
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento

Similar Documents

Publication Publication Date Title
JP2005526757A5 (https=)
CA2478406A1 (en) Therapeutic system for the controlled release of active ingredients
KR900700081A (ko) 부양성 경구용 투약 치료 기제(浮揚性 經口用 投藥 治療 基劑)
TWI394593B (zh) Methods of making pharmaceuticals for oral administration
JPS58174312A (ja) 持続的に放出する経口医薬付与装置
KR900011486A (ko) 하이드로겔에 의해 작동되는 분배장치
JP2002532406A5 (https=)
CY1106219T1 (el) Στepεο απο του στοματος χορηγουμενο φαρμακευτικο μορφωμα μεταβλητης απελευθερωσης που πepιεχει μια ασταθη στα οξεα της βενζιμιδαζολης
ATE427101T1 (de) Orales system zur verabreichung von gepulsten dosen eines arzneistoffs
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
DK0631775T3 (da) Farmaceutisk tablet, som trinvist kan frigive de aktive bestanddele
CN101652129B (zh) 口服制剂及其制造方法
CN101980702A (zh) 口服制剂
Parmar et al. Pulsatile drug delivery systems: an overview
JP2018065846A (ja) 哺乳類の消化管における一つあるいは複数の物質の放出制御製剤
KR20130010464A (ko) 고형 제제
DE60128263D1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
JP2007505894A5 (https=)
KR100666901B1 (ko) 제어 방출되는 활성물질 및/또는 보조물질을 함유하는약제 및, 그의 용도 및 제조
WO2003075894A8 (en) A system for the controlled release of active ingredients
JPWO2010035656A1 (ja) 経口投与剤
JP2005526061A5 (https=)
Siew Controlling drug release through osmotic systems
Prasanth et al. Pulsatile: a tool for circardian rhythm-a review
SK16952000A3 (sk) Laminát na priloženie na akceptor